RightWell GLP-1 Review 2026: Is the $159 Compounded GLP-1 Program With a 10% Guarantee Worth It?

SHERIDAN, Wyo., June 16, 2026 (Newswire.com) - Advertorial | Telehealth Platform Disclosure: RightWell is a technology platform operated by Prescribey, Inc. It doesn't practice medicine, employ clinicians, or prescribe medication. All prescribing is performed independently by a licensed medical practice (the "Practice") whose licensed providers make every clinical decision. Compounded medications are prepared and dispensed by certified U.S.-licensed pharmacy partners - separate entities from both RightWell and the Practice. Prescription medication is available only after clinical consultation and independent provider approval, if clinically appropriate. Approval is not guaranteed.

RightWell GLP-1 Research 2026: Pricing, Disclosures, and What to Know Before the FDA's June 29 Compounded GLP-1 Deadline

Article Scope Notice: This article covers RightWell's program pricing, structure, and disclosures as published in brand materials through June 16, 2026, with specific attention to the FDA's April 2026 proposal to restrict large-scale compounded GLP-1 availability and the June 29, 2026 public comment deadline. Promotional phrases appearing in this article - including "Doctor-Approved" and "Protects Muscle Tone" - reflect the RightWell brand's own published marketing language, not this publication's independent clinical endorsement. This article was not reviewed by a physician. Readers seeking what is verifiable, what is brand-stated, and what requires provider consultation should continue reading.

Disclosure: This article contains affiliate links. A commission may be earned on qualifying purchases made through links in this content, at no additional cost to the reader. Affiliate relationships do not influence editorial content or the evaluation of products. Disclosure is provided in accordance with FTC 16 CFR Part 255. This content is promotional in nature and is intended for consumer education regarding a commercially available product. Important: RightWell (Prescribey, Inc.) is a technology platform that does not practice medicine and does not prescribe medication. All prescribing decisions are made solely by licensed healthcare providers affiliated with an independent licensed medical practice. Prescription medication is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate. Approval is not guaranteed. Compounded medications available through this program are not FDA-approved.

Quick Answer - Is RightWell GLP-1 Legit? RightWell is a telehealth platform operated by Prescribey, Inc. that connects adults with licensed clinicians who can independently evaluate and - if clinically appropriate - prescribe compounded GLP-1 medications including semaglutide and tirzepatide. The brand calls the program "doctor-approved," meaning prescriptions are issued by independent licensed providers, not by RightWell itself. The compounded medications aren't FDA-approved. Pricing starts at a brand-stated $159 (promotional) or $179 (standard), and the program includes a 10% weight-loss guarantee on membership fees for eligible patients. One thing most buyers don't know: the FDA moved to restrict large-scale compounded GLP-1 availability in April 2026, with a public comment deadline of June 29, 2026 - this article covers what that means for a RightWell enrollment decision. Individual results vary. Prescription is not guaranteed.

See RightWell's Current GLP-1 Program, Pricing, and Spring Promo Details

RightWell GLP-1 2026 Fast Facts: What Every Buyer Should Know in 60 Seconds

• Product category: Compounded GLP-1 weight loss telehealth program

• Operator: Prescribey, Inc. (d/b/a RightWell), Sheridan, Wyoming

• Program structure: Three-entity model - RightWell (technology platform), independent licensed medical practice (prescribing), certified U.S. pharmacy partners (dispensing)

• Medications offered: Compounded GLP-1 medications including semaglutide and tirzepatide (brand-stated)

• Regulatory status: Compounded medications are NOT FDA-approved; prepared in FDA-registered facilities

• Starting price: $159 (brand-stated promotional price, Spring Promo auto-applied) / $179 (standard starting price per support documentation)

• Pricing transparency: Final pricing confirmed after medical evaluation; program fees include medication, delivery, and support per brand

• Insurance required: No - 100% self-pay program

• Weight loss guarantee: Brand-stated 10% weight-loss guarantee, subject to Terms of Service; refund applies to eligible membership fees only - medication costs, pharmacy fees, shipping, and third-party services are excluded

• Subscription model: Auto-renewing every 4 weeks; cancel via rightwell.com/billing or help@rightwell.com

• BMI requirement: Standard program requires BMI 25 or higher; Microdosing option available for lower BMI

• Card charged: Only after prescription is issued - not at signup

• Processing time: Prescription issued within 24-48 hours of completing intake; medication ships within 1-2 business days

• Delivery: Refrigerated, priority shipping included

• Included extras: ToneProtect™ BCAA supplement (free), insurance-backed dietitian referral, unlimited 24/7 clinical support via patient portal

• ToneProtect™ disclaimer: Dietary supplement not evaluated by FDA; not intended to diagnose, treat, cure, or prevent any disease

• Approval not guaranteed: Prescription medication available only after clinical evaluation by a licensed provider, if clinically appropriate

• Brand-stated stats: 18% average body weight loss, 92-93% kept weight off, 6x more weight loss than diet and exercise alone, 9/10 patients rate it most effective treatment (all brand-reported; individual results vary)

• Platform support: Phone 1-800-634-2814 (Mon-Fri 9am-6pm CST); Email help@rightwell.com; Patient portal 24/7

• Florida buyers: Florida Weight-Loss Consumer Bill of Rights posted; consult your physician before starting any weight loss program

• Emergency guidance: Telehealth services not for emergencies; call 911 for any medical emergency

• As of June 16, 2026: Program active; Spring Promo pricing ($100 OFF auto-applied) visible on official site per brand

• FDA regulatory window: June 29, 2026 = public comment deadline on FDA's April 30, 2026 proposal to permanently restrict large-scale compounded GLP-1 production; final determination to follow; program availability may be affected

• Urgency factor: 13 days remain in the public comment window as of this article's publication date (June 16, 2026); buyers evaluating compounded GLP-1 programs should factor the post-June-29 regulatory uncertainty into their timing decision

Quick Verification Snapshot - RightWell GLP-1 (Last Updated: June 16, 2026)

• Operator legal entity: Prescribey, Inc. - Publicly confirmed in brand's Terms of Use

• Business address: 1309 Coffeen Avenue Suite 1200, Sheridan, Wyoming 82801 - confirmed in brand's Terms of Use

• Phone: 1-800-634-2814 - confirmed in brand's support center documentation

• Email: help@rightwell.com - confirmed in brand's support center documentation

• Technology partner: Telegra MD, LLC - Named in brand's Terms of Use as platform implementation partner

• Prescribing model: Independent licensed medical practice (Telegra-contracted "Practice") makes all clinical decisions - confirmed in Terms of Use

• Pharmacy status: "Certified U.S. pharmacy partners" in FDA-registered facilities - confirmed in brand materials; individual partner names not publicly disclosed

• Medication type: Compounded GLP-1 (not FDA-approved) - confirmed in brand's own footer disclaimer

• Guarantee scope: Membership fees only; medication costs and pharmacy fees excluded - confirmed in Terms of Use, Section 17

• Subscription structure: Auto-renews every 4 weeks - confirmed in Terms of Use, Subscription Terms

• Trademark status: ToneProtect™ used with ™ mark per brand site; RightWell registration status not confirmed on brand site

• FDA regulatory window (June 2026): FDA proposed April 30, 2026 to remove semaglutide, tirzepatide, and liraglutide from the 503B Bulks List; public comment period closes June 29, 2026; final determination to follow

• Spring Promo status: $100 OFF auto-applied pricing visible on brand homepage as of June 16, 2026; "Ends Soon" per brand - confirm before enrolling

See RightWell's Current GLP-1 Program, Pricing, and Spring Promo Details

About the Promotional Language in This Article: "Doctor-Approved" and "Protects Muscle Tone" Explained

If you arrived here from a RightWell ad, you've already seen language like "doctor-approved" and claims about muscle tone protection while losing weight. This article discusses and attributes those phrases so you understand exactly what they mean - and what they don't mean - before you make a decision.

Here's exactly what each phrase means and doesn't mean:

• "Doctor-Approved" - Source: RightWell's official website and promotional materials. What it means: RightWell's program routes every patient through a licensed healthcare provider who independently evaluates their information and decides whether to prescribe. The provider, not RightWell, makes the clinical decision. What it does not mean: This publication has not conducted an independent clinical review of RightWell's protocols; the phrase reflects how RightWell describes its own program structure.

• "Protects Muscle Tone" - Source: RightWell's marketing copy for the included ToneProtect™ BCAA supplement. What it means: The brand positions ToneProtect™ as supporting muscle tone, skin tightness, and facial appearance during GLP-1 weight loss. What it does not mean: This claim has not been independently tested or substantiated by this publication; ToneProtect™ is a dietary supplement not evaluated by the FDA and not intended to diagnose, treat, cure, or prevent any disease.

Buyer Takeaway: The promotional phrases in this title come directly from RightWell's own marketing materials. This article uses them to match what you saw in the ad, then tells you what's verifiable, what's brand-stated, and what you should confirm before enrolling. That's a more useful article than one that uses softer language that no longer matches what brought you here.

What Is RightWell GLP-1, Really?

RightWell is a patient management platform operated by Prescribey, Inc., a technology company out of Sheridan, Wyoming. It doesn't practice medicine, prescribe medications, or dispense drugs - and it says so plainly in its own Terms of Use. What it does is connect adults who want access to compounded GLP-1 medications with two other parties: an independent licensed medical practice that makes all prescribing decisions, and a network of certified U.S. pharmacy partners that prepare and ship the medication.

That three-part structure matters if you're evaluating this program - you're not just signing up for a subscription box that mails you injections. You're entering a telehealth clinical pathway where a licensed provider has to review your information, conduct a virtual consultation, and independently decide you're an appropriate candidate for GLP-1 therapy before any medication ships.

GLP-1 medications - glucagon-like peptide-1 receptor agonists - work by mimicking natural hormones that regulate appetite and blood sugar. The brand describes them as working by "imitating natural hormones that control appetite and blood sugar, helping to boost metabolism and reduce cravings." Per brand materials, the medications available through RightWell's program include compounded versions of semaglutide and tirzepatide - active ingredients that share names with those in some of the most widely discussed branded GLP-1 treatments. Compounded versions are separate products that are not FDA-approved and not reviewed by the FDA for safety, effectiveness, or quality.

The "compounded" designation is important. Compounded medications are not FDA-approved products. They're prepared by licensed compounding pharmacies - in RightWell's case, pharmacy partners in FDA-registered facilities - but they don't go through the same pre-market approval process that brand-name drugs do. The brand's own footer makes this clear: "Some patients may be prescribed compounded GLP-1 medications prepared by U.S.-licensed pharmacies in compliance with applicable laws. These medications are prepared in FDA-registered facilities but are not FDA-approved or reviewed for safety, effectiveness, or quality." You'll see that disclosure again in the formal disclosure bundle at the bottom of this article.

Buyer Takeaway: RightWell doesn't prescribe or dispense anything - it arranges the connection between you, a licensed medical practice, and a compounding pharmacy. Compounded means not FDA-approved. Whether you qualify is entirely the licensed provider's call, not RightWell's. That's not a limitation - that's how compliant telehealth GLP-1 programs are supposed to work.

Semaglutide, Tirzepatide, and the Compounded GLP-1 Question: What Buyers Should Know

Quick Answer: RightWell GLP-1 source materials reference compounded semaglutide and tirzepatide, which share ingredient names with certain FDA-approved branded GLP-1 medications. Compounded medications are separate products - they're not FDA-approved and not reviewed by the FDA for safety, effectiveness, or quality. That distinction matters, and it's why this section exists. Understanding that distinction before you enroll isn't a technicality - it's the most important clinical fact in this entire review.

Semaglutide and tirzepatide are GLP-1 receptor agonists - a class of medications that work by mimicking hormones that regulate appetite and blood sugar. The brand-name versions of these compounds have gone through FDA's full drug approval process, which means the FDA reviewed clinical trial data for safety, effectiveness, and manufacturing quality before they reached the market. Compounded versions of these same active ingredients are a different category entirely.

Compounded medications are not FDA-approved. They're prepared by licensed compounding pharmacies - in RightWell's case, certified U.S. pharmacy partners operating in FDA-registered facilities - but they don't go through FDA's pre-market approval process. The FDA has published guidance noting that compounded drugs, because they haven't been approved, don't carry the same assurances of safety, effectiveness, or quality that approved drugs carry. RightWell's own footer says it plainly: medications are "prepared in FDA-registered facilities but are not FDA-approved or reviewed for safety, effectiveness, or quality."

This does not allow this publication to predict individual results or treat compounded formulations as equivalent to FDA-approved branded products. What it does mean is that the FDA hasn't independently reviewed RightWell's specific compounded formulations, and there's real variability across compounding pharmacies in concentration, inactive ingredients, and storage requirements - all things worth discussing with your licensed provider before starting.

Before starting any compounded GLP-1 program, including RightWell's, it's worth asking your assigned licensed provider:

• Is my medication semaglutide, tirzepatide, or another GLP-1 compound?

• What concentration and dose is prescribed?

• Which pharmacy is preparing my medication, and is it licensed in my state?

• Is an FDA-approved alternative available and appropriate for my situation?

• What are the storage requirements for my specific formulation?

• How do I measure and administer the dose correctly?

Those questions are clinical in nature - your licensed provider is who you want for those questions - through the patient portal, not the customer support line.

Buyer Takeaway: Compounded semaglutide and tirzepatide may involve active ingredients with the same names as those in certain FDA-approved branded GLP-1 medications - but compounded medications are separate products, not FDA-approved, and not reviewed by the FDA for safety, effectiveness, or quality. Pricing may differ by program, pharmacy, dose, and treatment plan. Understanding that regulatory distinction and discussing it with your licensed provider before starting is the right move. Any program that buries this instead of publishing it clearly isn't being straight with you - and RightWell puts it in its own footer.

See RightWell's Current GLP-1 Program, Pricing, and Spring Promo Details

How the RightWell Three-Entity Model Works

Most people who look at telehealth weight loss programs don't realize there are three separate organizations behind what feels like a single sign-up process. With RightWell, those three entities are distinct by design - and understanding who does what protects you as a consumer.

Entity 1: Prescribey, Inc. (d/b/a RightWell) - The Technology Platform. This is the company you interact with when you visit the website, complete the quiz, fill out the intake form, and manage your billing. RightWell explicitly states it is "not a medical group or a health care provider" but rather "a technology company that provides non-clinical services to assist individuals with their health care." Its job is administrative and operational: gathering your records, scheduling, coordinating payment, and facilitating the telehealth encounter. It does not practice medicine. It does not prescribe. It does not make clinical decisions about whether you receive medication.

Entity 2: The Independent Licensed Medical Practice - The Prescriber. Per the Terms of Use, RightWell engages Telegra MD, LLC as its technology implementation and administrative partner, and Telegra in turn provides services to a physician-owned and operated medical practice ("the Practice"). The Practice - which is separate from both RightWell and Telegra in its clinical function - employs a network of U.S.-based licensed clinicians who conduct the telehealth consultations and make all prescribing decisions independently. The Terms are explicit: "RightWell does not provide medical advice or care, own or operate the medical practices, employ or in any way supervise the clinicians providing medical care, and control over the care provided is the sole responsibility of the independent medical practices and the Providers they employ." When a licensed provider reviews your intake form and decides whether to issue a prescription, that decision belongs entirely to them - not to RightWell.

Entity 3: Certified U.S. Pharmacy Partners - The Dispensers. Once a licensed provider issues a valid prescription, RightWell routes it to one of its certified U.S. pharmacy partners. Per brand materials, these are licensed compounding pharmacies operating in FDA-registered facilities. They prepare your medication - typically a 4-week supply - and ship it refrigerated to your door via 1-2 business-day priority shipping. RightWell does not manufacture medications, and the brand notes that "product appearance may vary," which is standard for compounded preparations. Individual pharmacy partner names are not publicly disclosed by the brand.

Prescription medication is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate. Approval is not guaranteed.

Buyer Takeaway: You're not clicking "buy" on medication - you're entering a clinical structure where the prescribing decision is made by someone completely independent of the company billing your card. RightWell publishes that separation in its Terms of Use, which is more than most programs in this category do.

How to Read RightWell's Marketing Language

RightWell's promotional copy is confident and specific. Before you use those numbers to make a decision, it's worth understanding exactly what each of them means - and what standard was used to arrive at them.

• "Join over 10 million people who have lost weight using GLP-1s" - This refers to GLP-1 medication users broadly, not to RightWell patients specifically. It's a category-level figure, not a program enrollment number.

• "6x more weight loss than exercise and diet alone" - Brand-stated comparative claim. We haven't reviewed the underlying data source. Individual results vary based on medication, adherence, dosing, and individual physiology.

• "Lose an average of 18% of your body weight" - Brand-reported average. The brand's own disclaimer notes: "All references to results or benefits are based on self-reported user experiences. Individual results vary and depend on adherence to the treatment plan and provider guidance. No results are guaranteed."

• "Over 92% kept the weight off for good" / "93% kept the weight off" - Two figures appear on the homepage (92% in one section, 93% in another). Both are brand-reported. This publication has not independently audited these statistics.

• "9/10 patients call it the most effective treatment to date" - Brand-reported patient satisfaction metric. Not an independently audited survey result.

• "Doctor-Approved" - As explained in the dedicated section above, this refers to the program's clinical structure, not to this publication's independent endorsement.

The brand's homepage footer states: "Some testimonials on this site are of paid endorsers. Individual results may vary." That's an important baseline acknowledgment. Customer ratings and testimonials are brand-reported, not independently audited by this publication. Individual experiences vary.

Buyer Takeaway: RightWell's statistics are presented by the brand. The category-level GLP-1 research base is substantial - but the specific percentages RightWell uses are brand-reported figures, and you should confirm their sourcing directly with the brand before treating them as independently verified data.

Does RightWell GLP-1 Actually Work? What the Research Says - and What It Doesn't

Quick Answer: RightWell GLP-1 functions as a telehealth pathway that may connect eligible adults with licensed providers who can evaluate whether compounded semaglutide or tirzepatide could be clinically appropriate. Whether treatment is right for you depends on independent provider approval, consistent use over at least 16 weeks, and your individual response. No results are guaranteed. Approval is not guaranteed. Individual experiences vary.

Quick Answer - FDA's June 29 Deadline: In April 2026, the FDA proposed permanently ending large-scale production of compounded semaglutide and tirzepatide. The public comment period on that proposal closes June 29, 2026 - 13 days from today. After that, the FDA issues a final determination. No one knows exactly what changes when, but anyone seriously researching compounded GLP-1 programs right now should factor this into their timing. That's the single most time-sensitive thing in this article.

RightWell is a facilitation platform - it doesn't create the medication's effect; the GLP-1 compound does. So the more useful question is: does GLP-1 therapy, when it's appropriately prescribed and consistently used, produce meaningful weight loss for most people?

The published research on GLP-1 receptor agonists is among the most robust in recent obesity medicine. Studies on semaglutide and tirzepatide have been published in leading peer-reviewed journals, and the compounds are approved in branded forms for specific indications by the FDA. The mechanisms are well established: GLP-1 receptor agonists slow gastric emptying, reduce appetite signaling, and help regulate blood sugar - a combination that tends to reduce caloric intake and support weight management.

What RightWell specifically offers is compounded versions of these compounds - not the branded FDA-approved products. Compounded medications use the same active ingredients but are prepared by compounding pharmacies rather than going through FDA's drug approval process. This distinction matters because compounded medications don't carry the same regulatory review as brand-name drugs, though they are prepared in FDA-registered facilities.

Published clinical literature on FDA-approved GLP-1 receptor agonists supports their role in weight management for appropriate patient populations under medical supervision - but that's not the same as independently verifying RightWell's specific compounded formulations. Individual response varies significantly. Not everyone loses 18% of body weight. Not everyone tolerates these medications at every dose. Side effects - nausea, gastrointestinal discomfort, and others documented in clinical literature - are real, variable, and should be discussed with your provider before starting. That clinical review before any prescription is issued is why the three-entity structure exists.

Rapid weight loss carries its own risks, and Florida law requires weight-loss programs to disclose them directly to consumers. The Florida Weight-Loss Consumer Bill of Rights states: "WARNING: RAPID WEIGHT LOSS MAY CAUSE SERIOUS HEALTH PROBLEMS. RAPID WEIGHT LOSS IS WEIGHT LOSS OF MORE THAN 1½ POUNDS TO 2 POUNDS PER WEEK OR WEIGHT LOSS OF MORE THAN 1 PERCENT OF BODY WEIGHT PER WEEK AFTER THE SECOND WEEK OF PARTICIPATION IN A WEIGHT-LOSS PROGRAM." This applies to all participants, including those using GLP-1 medications. Consult your personal physician before starting any weight loss program.

Buyer Takeaway: GLP-1 therapy has a significant published research base for weight management, and the underlying mechanisms are well understood. RightWell connects you to that class of medication through a clinical structure. Whether it works for you depends on whether you're an appropriate candidate (the licensed clinician decides), whether you're consistent (the guarantee requires 16 uninterrupted doses), and how your body responds to GLP-1 therapy specifically.

RightWell GLP-1 Pricing: What You'll Actually Pay

Quick Answer: RightWell GLP-1 pricing starts at $159 (current promotional, Spring Promo auto-applied) or $179 (standard, per support documentation). Final pricing depends on your specific treatment. Program fees include medication, delivery, and support. Your card isn't charged until your prescription is issued. Confirm current pricing at the official site before enrolling.

Pricing is where a lot of compounded GLP-1 programs frustrate buyers, and it's worth being precise about what RightWell publicly states versus what you'll know after evaluation.

Everything below comes directly from RightWell's published materials - not from any independent price analysis:

• Homepage price: $159 with the Spring Promo auto-applied - that's $100 OFF the standard rate

• Standard price: $179 per the brand's support center documentation

• What's included: Medication, delivery, and support per program fees

• What the guarantee doesn't cover: Medication costs, pharmacy fees, shipping, and lab testing - the refund is on membership fees only

• Insurance: Not accepted - 100% self-pay

• Hidden fees: Brand says none; exact pricing is confirmed after your evaluation, not before

• Price varies: Based on your specific treatment and medication - you'll get the exact number after your clinical intake

On the subscription structure: this program auto-renews every 4 weeks, not monthly. That's a meaningful distinction. If your month has 31 days, a 4-week billing cycle means you'll see approximately 13 billing events per year rather than 12. Your card is charged every 4 weeks automatically unless you cancel. The brand states pricing may change every 4 weeks with at least 10 days' advance notice.

Shipping and tax components are calculated separately at checkout. Confirm your total before completing enrollment. Before-price comparisons or reference prices shown on the site are the brand's stated reference points and may not reflect prevailing market prices.

Buyer Takeaway: There's a meaningful gap between the $159 promotional price and the $179 standard price - both are published by the brand in different locations. The Spring Promo appears to account for that difference. Verify current pricing on the official site before completing enrollment, confirm what's included in your specific treatment tier, and make sure you understand the 4-week billing cycle before providing your payment method.

Check Current RightWell Pricing and Promotion at the Official Site

The RightWell 10% Weight Loss Guarantee - Full Terms, No Surprises

Quick Answer: RightWell GLP-1's 10% guarantee refunds membership fees - not medication costs - if you don't lose at least 10% of starting body weight in 4 consistent months (16 uninterrupted weekly doses). New patients only. Request within 14 days of month four. Pharmacy, shipping, and medication costs are excluded.

RightWell offers what it calls a "10% Weight Loss Guarantee" - one of the more specific and verifiable guarantees in the compounded GLP-1 space. Here's exactly what it covers, what it doesn't, and what you need to do to qualify.

What the guarantee promises: If you commit to your personalized GLP-1 treatment plan and don't lose at least 10% of your starting body weight within 4 months, RightWell will refund your membership fees in full for that period.

What the guarantee covers: A 100% refund of RightWell membership fees paid during your first 4 months.

What the guarantee does not cover: Medication costs, pharmacy or shipping fees, and lab testing or third-party services. This is an important exclusion - if you paid significantly more for medication than for membership fees, the refund represents a fraction of your total spend.

The guarantee has teeth, but so does the eligibility list. To qualify, you have to be a first-time patient, submit your starting weight at onboarding, take every weekly dose for 16 consecutive weeks without gaps, avoid outside weight-loss programs during the 4 months, and still not hit 10% total weight loss after all of that. Miss any one of those, and you're outside the guarantee window - even if your results are disappointing.

How to claim: Submit a refund request within 14 days of your fourth month ending by emailing help@rightwell.com. You'll verify your weight via a signed letter from a licensed healthcare provider or a recorded video weight check using a verification code RightWell provides. Refund decisions are made within 7-10 business days; approved refunds are processed within 30 days.

Additional scenarios: If you're not medically approved after intake, you receive a full refund automatically. If you had to stop due to provider-advised side effects or contraindications, you may be eligible for a partial refund prorated by time and usage.

Buyer Takeaway: This guarantee is real, specific, and has published eligibility criteria - but it covers membership fees only, not medication costs. The consistency requirement (16 uninterrupted weekly doses over exactly 4 months) is the strictest eligibility gate. There's also a timeline built into the guarantee that works in favor of starting sooner: every week you wait before enrolling is one week further from knowing whether the program works for you within the guarantee window. That's not manufactured urgency - it's how 4-month consistency programs work mathematically. Verify current guarantee terms directly at rightwell.com before enrolling.

ToneProtect™ BCAA Supplement - What the Free Add-On Actually Is

RightWell differentiates itself in part by including ToneProtect™, a BCAA (branched-chain amino acid) supplement, free with your program. The brand positions this as addressing one of the documented concerns with GLP-1 weight loss: the potential for muscle loss alongside fat loss.

The brand's own description: ToneProtect™ "Helps protect muscle tone, skin tightness, and facial appearance while losing weight on GLP-1s."

The mandatory disclosure the brand itself publishes: "Dietary supplements sold by RightWell, including Tone Protect, have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Supplements are not a substitute for medical care. Consult a healthcare professional before use."

BCAAs - specifically leucine, isoleucine, and valine - are amino acids that play a role in muscle protein synthesis. The research base for BCAA supplementation in the context of caloric restriction and muscle preservation is an area of ongoing study; the NIH and NCCIH have published materials on amino acid supplementation, though findings vary by population, dosage, and context. This publication has not reviewed ToneProtect™'s specific formulation, ingredient quantities, or sourcing.

The brand also includes an insurance-backed dietitian referral - access to a registered dietitian whose services may be covered by your existing insurance - to support sustainable eating habits during and after your treatment program.

Buyer Takeaway: ToneProtect™ is a free BCAA supplement - not a medical device, not an FDA-approved product. The muscle-tone positioning is the brand's marketing language. Worth discussing with your assigned clinician; not worth treating as a clinical promise.

RightWell Subscription Terms: The 4-Week Billing Cycle You Need to Know About

Here's where most GLP-1 telehealth reviews get it wrong - they call it a "monthly" subscription when it isn't. RightWell bills every 4 weeks, not every calendar month. That's 13 billing events per year, not 12. Small distinction, real budget impact.

The full subscription structure, confirmed in RightWell's Terms of Use:

• Billing frequency: Every 4 weeks, continuous until canceled

• What's charged: Your card on file is debited automatically each period for the amount in your current subscription

• Price change notice: RightWell will provide at least 10 days' advance notice before a changed amount is transferred

• How to cancel: Visit rightwell.com/billing OR email help@rightwell.com - cancel any time before the end of your current billing period

• What happens after cancellation: Access to services ends at the end of your current billing period; you're not charged for the next period

• What happens if payment fails: RightWell reserves the right to cancel your subscription without notice

• When your card is first charged: Not at signup - only after your prescription has been issued by the licensed provider

• Refills: Each 4-week cycle, a new prescription and shipment are issued according to your clinician's treatment schedule

Per California Business and Professions Code §17600 and ROSCA (15 U.S.C. §8401), auto-renewal programs require clear disclosure of recurring billing terms before enrollment. RightWell publishes these terms in its Terms of Use. Confirm current terms at rightwell.com before completing enrollment.

Buyer Takeaway: You can't set this one and forget it. RightWell auto-bills every 4 weeks unless you actively cancel. If your clinical situation changes, if you want to pause, or if you're not happy with your progress, cancellation is straightforward - but you have to initiate it. Mark your calendar or set a reminder after your 4-month evaluation window closes, especially if you're planning to assess your results and then decide whether to continue.

Who Qualifies for RightWell? BMI Requirements and the Microdosing Option

RightWell's standard GLP-1 program requires a BMI of 25 or higher. That's the baseline clinical threshold the brand applies, consistent with standard clinical guidelines for considering GLP-1 therapy for weight management.

But RightWell has a pathway for people who don't meet that threshold: the Microdosing program. According to the brand's support documentation, a RightWell clinician may approve a Microdosing plan for patients who don't qualify under the standard BMI requirement, as long as all other health and safety criteria are met. With Microdosing, the dose remains stable throughout the treatment (rather than titrating upward), and it's also available as a maintenance option for existing patients who've already reached their weight loss goals and want a lower, steady dose to stay on track.

To find out if you qualify - whether for the standard program or Microdosing - the process starts with the quiz on rightwell.com. If your BMI doesn't meet the standard threshold, your case may be flagged for Microdosing eligibility review by a licensed clinician.

Additional eligibility notes:

• Platform is available only to users located in U.S. states where the platform is active. Services are not available outside the United States.

• Users must be at least 18 years old

• All clinical determinations - including whether you qualify, what medication is appropriate, and at what dose - are made by the licensed provider, not by RightWell

• Starting at a higher dose is possible if you were on GLP-1 therapy with a previous provider: your starting dose can match your prior prescription (no higher) with documentation not older than 30 days

Buyer Takeaway: Don't assume you don't qualify because your BMI is under 25. There's a Microdosing pathway worth asking about. And don't assume you automatically qualify because your BMI is over 25 - the licensed clinician reviews all criteria and makes an independent determination. Completion of the assessment doesn't create a doctor-patient relationship or guarantee a prescription.

RightWell vs. Other Compounded GLP-1 Programs: What's Different

The compounded GLP-1 telehealth category has gotten crowded since 2023. Here's what RightWell's publicly disclosed program structure shows that makes it distinct from the generic category description:

• No-charge-until-prescribed model: Many programs charge upfront or at enrollment. RightWell explicitly states your card is not charged until a prescription is issued. This limits your financial exposure if you don't qualify.

• Explicit three-entity separation: RightWell publishes - in its Terms of Use - the clear separation between platform, prescribing practice, and pharmacy. Not every program makes this explicit in consumer-facing documentation.

• ToneProtect™ BCAA free add-on: A muscle-preservation supplement included at no additional cost is a program differentiator, though it carries an FDA supplement disclaimer.

• Insurance-backed dietitian referral: Structured post-program support that helps patients maintain results is documented in the brand's program materials. Not all compounded GLP-1 platforms include this.

• Defined weight loss guarantee with published terms: The 10% guarantee has specific published eligibility criteria in the Terms of Use. Many programs' guarantee terms are vaguer.

• Microdosing pathway for sub-25 BMI: A documented option for people who don't meet standard clinical thresholds is uncommon in the category.

• Explicit "approval not guaranteed" language: RightWell's own Terms make clear that completing an intake doesn't guarantee a prescription. That transparency is the right posture for a clinical program.

What RightWell shares with the broader category: compounded medications are not FDA-approved regardless of which platform facilitates them. The FDA-registered facility status of the compounding pharmacies is the relevant compliance benchmark, not FDA drug approval. Every compounded GLP-1 program, including RightWell, operates under the same regulatory framework for compounding.

Buyer Takeaway: RightWell's published documentation covers more of its program structure than many thin affiliate reviews in this category typically explain. That transparency - in the Terms of Use, in the footer disclaimers, in the support center documentation - is a meaningful signal compared to programs that bury these details or don't publish them at all.

Start Your RightWell Assessment and See If You Qualify

Who Is RightWell GLP-1 a Good Fit For?

RightWell isn't the right fit for everyone. Here's an honest look at who it's designed for - and where it tends to land well.

RightWell may be worth exploring if you:

• Have a BMI of 25 or higher (or are open to asking about the Microdosing pathway if you don't), and you've already spoken with your own doctor about GLP-1 therapy as a weight management option

• Are self-pay and don't want to navigate insurance approval for GLP-1 medications - the 100% self-pay model eliminates insurance gatekeeping, though it also means no insurance cost-sharing

• Want telehealth convenience - completing intake, consulting with a provider, and receiving medication without in-person visits is genuinely different from a traditional clinical pathway

• Understand compounded medications - specifically that they're not FDA-approved and you've discussed that with a healthcare provider

• Can commit to a 4-week billing cycle and 16 consecutive weekly doses - especially if you want to qualify for the 10% weight loss guarantee

• Want clinical structure, not just a supplement - RightWell's clinical pathway (provider review, licensed prescribing, pharmacy dispensing) is different from buying a weight loss supplement online without any clinical oversight

Buyer Takeaway: RightWell isn't a passive purchase. It's an entry into a clinical pathway that requires medical intake, provider approval, consistent weekly dosing, and active engagement with the patient portal for clinical questions. If you're ready for that structure and understand the compounded medication disclosure, it's a program worth evaluating. If you're looking for a quick supplement purchase with no clinical gatekeeping, this isn't that product.

Who Should Have a Conversation With Their Own Doctor First

GLP-1 receptor agonists are potent medications, and their side effects are well-documented - including nausea, vomiting, diarrhea, and constipation - that vary significantly by individual. Some people tolerate them easily from the first dose. Others need dose adjustments, temporary pauses, or close clinical monitoring. A few people aren't good candidates at all due to contraindications.

You should speak with your own primary care provider before starting any GLP-1 program, including RightWell, if you:

• Have a history of pancreatitis, thyroid cancer, or multiple endocrine neoplasia syndrome type 2 (MEN 2) - conditions associated with contraindications to GLP-1 medications per clinical literature

• Are currently taking other medications that might interact with GLP-1 therapy, including insulin, other blood sugar medications, or medications with narrow therapeutic windows

• Have significant kidney or liver disease, heart failure, or other serious systemic conditions

• Are pregnant, planning to become pregnant, or breastfeeding

• Have a history of disordered eating or a complex relationship with food and weight

• Have experienced adverse reactions to GLP-1 medications in the past

RightWell's clinical pathway includes provider review of your health information before prescribing - that review should catch contraindications. But it doesn't replace the relationship with your own doctor who has your complete longitudinal health history. These aren't mutually exclusive: you can use RightWell's telehealth pathway and maintain your relationship with your own primary care provider simultaneously. The brand's Terms of Use explicitly recommend it: "We strongly recommend all patients maintain a relationship with a local primary care provider for their ongoing medical care and treatment."

GLP-1 medications can be associated with side effects, and individual tolerance varies significantly. Always discuss risks, contraindications, dosing instructions, and side-effect concerns with a licensed healthcare professional before starting treatment. For severe symptoms or any medical emergency, call 911 or seek emergency medical care immediately - telehealth services are not for emergencies.

Buyer Takeaway: RightWell's clinical structure is a genuine safeguard, not just a legal formality. The licensed provider review before any prescription is issued exists to protect you. But it works best as a complement to - not a replacement for - your own healthcare provider relationship. If you have any significant medical history, bring your RightWell evaluation into that relationship before your first dose.

What to Ask Before You Enroll in RightWell

These questions aren't here to talk you out of enrolling. They're here to make sure you have what you need to decide with confidence - and to give you a ready-made checklist for your first patient portal message to your assigned provider.

On the medication:

• Which specific GLP-1 compound will I receive - semaglutide, tirzepatide, or another option?

• What is the starting dose, and what's the expected dose escalation schedule?

• What concentration is my specific formulation?

• How do I store my medication once it arrives?

• How do I administer the injection correctly?

• What should I do if I miss a dose?

• Is an FDA-approved alternative available and appropriate for my situation?

On the clinical process:

• Who reviews my intake, and what credentials do they have?

• What happens if I'm not approved?

• What happens if I have a side effect that requires attention between regular check-ins?

• How do dose changes work if I'm not tolerating the current dose well?

On the program and pricing:

• What exactly does my $159 (or $179) starting price include?

• What does my specific treatment tier cost per 4-week cycle?

• What's included vs. billed separately?

• What exactly does the 10% guarantee cover - and what does it exclude for my specific enrollment?

• How do I cancel, and what's my next billing date?

• If medication availability changes, what are my options?

On the pharmacy:

• Which pharmacy is preparing my medication?

• Is that pharmacy licensed in my state?

• What quality controls does the pharmacy use?

You don't need to ask all of these before taking the quiz. But you should have answers to the ones that matter most to you before your first shipment arrives and your first 4-week billing cycle begins.

Buyer Takeaway: The patient portal (app.rightwell.com) is your direct line to your assigned clinical team for any of these questions. Administrative questions about billing and cancellation go to 1-800-634-2814 or help@rightwell.com. The two channels are separate by design - use the right one for the right question and you'll get faster answers.

The FDA's June 29, 2026 Compounded GLP-1 Deadline: What RightWell Buyers Need to Know Right Now

If you've been researching compounded GLP-1 medications for any length of time, you've encountered questions about the regulatory future of compounded semaglutide and tirzepatide. Here's the context that's relevant to a decision made in June 2026.

The most important regulatory fact for anyone evaluating a compounded GLP-1 program in June 2026 isn't buried in this article - it's in the title. The FDA's public comment period on permanently restricting large-scale compounded GLP-1 production closes June 29, 2026. That's 13 days from today.

Here's how it got to this point. GLP-1 shortages hit in 2022, which opened a legal door: when FDA-approved drugs are in shortage, licensed compounding pharmacies can prepare and dispense them. That's what fueled the entire compounded GLP-1 telehealth market. Both shortages are now resolved - semaglutide in February 2025, tirzepatide in October 2024 - which means that legal door is swinging shut.

On April 30, 2026, the FDA formally proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulk drug substances list. Per legal analysis published by Orrick LLP and reporting from Pharmacy Times (updated June 16, 2026), this proposal would "foreclose any future pathway for bulk compounding, even in the event of a new shortage designation" - meaning this isn't a pause, it's a proposed permanent closure for large-scale 503B production. Several major 503B compounding facilities have already ceased production in anticipation. The Federal Register docket (2026-08552) is open for public comment through June 29, 2026. After that, the FDA will review comments and issue a final determination. A separate 503A framework applies to patient-specific compounding by state-licensed pharmacies, and that pathway has different restrictions - ask your RightWell provider directly which framework applies to your prescription.

The FDA has also issued warning letters in 2026 to GLP-1 telehealth companies making false or misleading claims about compounded medications - specifically targeting phrases like "same active ingredient as Ozempic" and "generic Zepbound." Programs that publish accurate compounded-not-FDA-approved disclosures in their own materials - as RightWell does - are on the right side of that enforcement activity.

This is a factual urgency window, not manufactured scarcity. If you've been researching compounded GLP-1 programs and haven't started yet, the regulatory timeline is a real factor in your decision. Buyers who start now with full knowledge of the June 29 comment deadline and the 503B enforcement trajectory are better positioned than buyers who discover it after committing to a multi-month program.

Buyer Takeaway: Here's what's verifiable today: compounded GLP-1 medications are available through programs like RightWell as of June 16, 2026. Here's what isn't known: what changes after the FDA finalizes its proposal. If you're planning to start a compounded GLP-1 program, ask your RightWell clinician directly through the patient portal what their pharmacy network's status is. Don't wait for regulatory certainty that may not come before the comment period closes.

RightWell GLP-1 Data Privacy and Telehealth Consent: What You're Agreeing To

When you enroll in a telehealth health program, you're sharing health information with multiple parties. Here's what RightWell's published materials tell you about that:

Privacy Framework: RightWell's Privacy Practices reference CareValidate, Inc. as the privacy and data management framework for clinical information handled through the platform. CareValidate's Privacy Policy (last updated February 1, 2025) governs how patient data collected through the platform is handled. The data controller of your personal data is identified as your provider or the Practice, not RightWell itself.

Telemedicine Consent (Telegra MD): By enrolling, you consent to telemedicine services performed by Telegra MD. This includes electronic communication of your personal medical information to healthcare providers who may be located in other states, potential recording of consultations for quality assurance, and the associated risks of telehealth (including rare technology failures and their impact on care quality).

What you should review before enrolling:

• RightWell Privacy Practices at rightwell.com

• Telehealth Consent for Services Performed by Telegra MD (available via RightWell)

• CareValidate Privacy Policy for clinical data handling specifics

• RightWell's Terms of Use, Section 4 and 19 (consent to recording, communications)

HIPAA note: The telehealth consent acknowledges that "the laws that protect privacy and the confidentiality of medical information also apply to telemedicine." Clinical data shared through the platform is subject to HIPAA privacy protections, administered through the licensed clinical entities involved in your care.

Buyer Takeaway: Your health data moves through several entities here - the platform, the prescribing practice, the pharmacy, and their admin partners. Read RightWell's Privacy Practices and Telemedicine Consent before you complete enrollment, especially if you want to know exactly who sees what and under what circumstances.

RightWell GLP-1 Final Verdict (June 2026)

Here's the straight answer for anyone who came to this review wanting one.

RightWell is a clearly structured telehealth GLP-1 access program that publishes several consumer-facing details buyers should review carefully: explicit platform separation in its Terms of Use, compounded-not-FDA-approved status disclosed in its own footer, a structured clinical support pathway through licensed providers, and a guarantee with specific published eligibility criteria. Those details matter for buyers who want to understand what they're actually signing up for.

Those details matter - they're the difference between a clinical program and a supplement checkout. If that clinical structure matters to you, RightWell delivers it.

What you need to be clear-eyed about: prescription approval isn't guaranteed. The 10% weight loss guarantee covers membership fees - not the full program cost including medication. The subscription bills every 4 weeks, not monthly. And compounded GLP-1 medications, while using the same active ingredients as brand-name drugs, haven't been through FDA's pre-market approval process. If any of those facts give you pause, that pause is worth honoring - ask your licensed provider about them before your first shipment arrives.

RightWell GLP-1 may be worth enrolling in if you meet the BMI threshold, you've already had a conversation with your own doctor about GLP-1 therapy being appropriate for you, you understand the self-pay and subscription model, and you're ready to commit to consistent weekly dosing for at least 4 months. If those conditions are true, RightWell's published program structure includes transparency signals that buyers can verify directly - more than many programs in this category publish.

RightWell GLP-1 may not be the right starting point if you haven't yet had a baseline conversation with your own healthcare provider about GLP-1 suitability for your specific health profile. Not because RightWell's clinical review isn't real - it is - but because your own provider has your complete health history and can give you context the telehealth intake form can't replicate.

The strongest reason to consider RightWell is the combination of clinical structure and published transparency. The most important reason to slow down is that prescription approval, medication access, pricing, and outcomes are not guaranteed. Both of those things are true simultaneously.

Buyer Takeaway: RightWell GLP-1 offers transparency signals that matter in this category: explicit platform-prescriber separation published in its Terms of Use, compounded medication disclosures in its own footer, detailed billing terms, and a guarantee with specific eligibility criteria. The FDA has issued warning letters to GLP-1 telehealth companies making false or misleading claims - context that makes a program publishing its own compounded-not-FDA-approved disclaimers stand out. Those signals are verifiable in the brand's own documentation, not just our summary of it. The program is worth evaluating if you meet the criteria and understand what you're signing up for. It's not for everyone, and the brand itself says so.

See If You Qualify for RightWell's GLP-1 Program - Assessment Only, No Charge Until Prescribed

RightWell 2026 Buyer FAQ

Is RightWell a legitimate GLP-1 telehealth program?

RightWell is operated by Prescribey, Inc., a registered company with a published physical address (1309 Coffeen Avenue Suite 1200, Sheridan, Wyoming 82801), phone number (1-800-634-2814), and email (help@rightwell.com). The program routes prescriptions through licensed medical practices and certified U.S. pharmacy partners in FDA-registered facilities. The brand is transparent about its three-entity structure, its subscription terms, and the compounded (not FDA-approved) status of its medications. Those are the verifiable markers of a legitimate telehealth operation. Whether the program is right for you clinically is a determination made by the licensed provider who reviews your intake, not by this publication.

Is RightWell FDA-approved?

No. The compounded GLP-1 medications facilitated through RightWell's program are not FDA-approved. The brand's own footer states: "Some patients may be prescribed compounded GLP-1 medications prepared by U.S.-licensed pharmacies in compliance with applicable laws. These medications are prepared in FDA-registered facilities but are not FDA-approved or reviewed for safety, effectiveness, or quality." The pharmacy partners operate in FDA-registered facilities, which means they meet certain facility standards - but the compounded medications themselves have not gone through FDA's drug approval process. This is true for all compounded GLP-1 programs, not RightWell specifically.

Does RightWell prescribe medication itself?

No. RightWell is a technology company. Per its Terms of Use: "RightWell is not a medical group or a health care provider." Prescriptions are issued by licensed providers affiliated with the independent medical practice (the "Practice") that contracts with Telegra MD, LLC for administrative support. RightWell facilitates the connection; the licensed provider makes the clinical decision. Prescription medication is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate.

What GLP-1 medications does RightWell offer?

Based on published brand materials, RightWell facilitates access to compounded GLP-1 medications including semaglutide and tirzepatide. Exact medication options and available formulations are confirmed during and after your clinical evaluation. The brand's support documentation references both in the context of the weight loss guarantee eligibility (referencing "e.g., semaglutide or tirzepatide").

What is the RightWell money-back guarantee?

RightWell's 10% weight loss guarantee covers membership fees paid during your first 4 months if you follow the program consistently (16 uninterrupted weekly doses) and don't achieve at least 10% total weight loss. The guarantee explicitly excludes medication costs, pharmacy fees, shipping, and lab testing. You must request the refund within 14 days of your fourth month ending and verify your weight via licensed provider letter or video weight check. Refund decisions take 7-10 business days; approved refunds process within 30 days.

How long does it take to get your first RightWell shipment?

Per the brand's support documentation, the prescription is issued within 24-48 hours of completing all intake requirements and receiving clinician approval. Once prescribed, medication ships via 1-2 business-day priority shipping in a refrigerated package. Tracking information is provided. Your card is not charged until the prescription is issued.

Can you switch to RightWell from another GLP-1 program?

Yes, per the brand's documentation, if you've been on GLP-1 therapy with another provider, you may be able to start at a higher dose rather than restarting at the lowest dose. You'll need proof of an existing prescription no older than 30 days, in your name, for the same GLP-1 medication, with your current dose clearly shown. Your starting dose with RightWell can match - but not exceed - your prior prescription. Your clinician makes this determination after reviewing your documentation.

Can you qualify for RightWell with a BMI under 25?

Standard GLP-1 eligibility requires a BMI of 25 or higher. However, RightWell offers a Microdosing option for patients who don't meet this threshold but otherwise meet health and safety criteria. A licensed clinician reviews and approves Microdosing eligibility. Microdosing is also available as a maintenance option for patients who've reached their weight loss goals and want a stable lower dose going forward.

How do you cancel your RightWell subscription?

Cancel at any time before the end of your current 4-week billing period by visiting rightwell.com/billing or emailing help@rightwell.com. Cancellation takes effect at the end of your current billing period - you're not charged for the next cycle. If you need to cancel immediately or have questions about your billing status, the support team is reachable Monday-Friday, 9am-6pm CST at 1-800-634-2814.

Is the RightWell Spring Promo still active?

As of June 2026, the Spring Promo offering $100 OFF plus a free ToneProtect™ BCAA supplement was displayed on the RightWell homepage with the notation "Ends Soon - AUTO APPLIED." Promotional pricing is subject to change and expiration without notice. Confirm current promotional status and pricing at the official site before completing enrollment.

Is compounded GLP-1 medication still available after the FDA's June 29, 2026 deadline?

Yes, as of June 16, 2026. The June 29 date is when the FDA's public comment period closes - not when a final rule takes effect. After comments close, the FDA reviews submissions and then issues a final determination, which is a separate step. So the compounded GLP-1 market doesn't flip off like a switch on June 30. What's already happened: multiple large 503B production facilities have wound down in anticipation. What's unclear: the 503A patient-specific pharmacy pathway operates under different rules and may continue under certain conditions. For what this means for your specific prescription, ask your RightWell provider through the patient portal - they'll know what their pharmacy partners are doing.

Will RightWell still be available after June 29, 2026?

Unknown - and anyone who tells you otherwise is guessing. RightWell is a technology platform, not a pharmacy, so its survival depends on whether its pharmacy network can continue producing compounded GLP-1 medications after the FDA finalizes its proposal. That final determination hasn't happened yet. The practical move: call 1-800-634-2814 or email help@rightwell.com and ask directly what their pharmacy partners' current status is. Real companies answer that question. The answer tells you more than any review article will.

Is it better to start a compounded GLP-1 program before or after the June 29 deadline?

Your enrollment timing doesn't change what the FDA does - but it changes how much of your 4-month guarantee window sits inside the current regulatory framework versus after the final determination. If you're going to enroll anyway, starting now means your 16-week consistency clock (required for the guarantee) starts now. Waiting for regulatory certainty that may not arrive before June 29 is a real decision cost. That said: no one should rush a health decision. The right timing is when you've spoken with your own doctor, you understand what you're signing up for, and the program makes sense for your situation.

What clinical support does RightWell include?

All RightWell patients have access to 24/7 clinical support through the secure patient portal at app.rightwell.com. Unlimited doctor consults are included at no extra cost. Phone and email support handle administrative, billing, and general questions. Clinical questions - about treatment, side effects, dosing, and medication specifics - are handled exclusively through the patient portal for HIPAA compliance.

What happens if you can't tolerate the medication?

If you have to stop due to provider-advised side effects or contraindications, RightWell states you may be eligible for a partial refund prorated based on time and usage. Any dose change or discontinuation decision is made by your assigned licensed clinician, not by RightWell. Contact your clinician through the patient portal (app.rightwell.com) for any medication concerns. For emergencies, call 911 immediately - telehealth services are not for emergencies.

Does RightWell accept insurance?

No. The program is 100% self-pay. RightWell is not an insurer and doesn't participate in Medicare, Medicaid, or any other insurance plan. The dietitian referral included with the program is insurance-backed, meaning dietitian services (not the RightWell program itself) may be covered by your existing insurance where applicable.

How does the ToneProtect™ supplement relate to GLP-1 therapy?

GLP-1 medications produce weight loss partly through reduced caloric intake, which can include some loss of muscle mass alongside fat loss. RightWell includes ToneProtect™, a BCAA supplement, positioned by the brand as helping protect muscle tone, skin tightness, and facial appearance during the weight loss process. This is a brand-stated positioning - ToneProtect™ is a dietary supplement not evaluated by the FDA and not intended to diagnose, treat, cure, or prevent any disease. Discuss supplement use with your assigned clinician.

What states is RightWell available in?

Per Terms of Use, RightWell is subject to state and federal regulations, and the platform may not be available in all states. Services are available to users in U.S. states where the platform is active. Services are not available outside the United States. Confirm availability in your state before completing enrollment - the assessment process itself will surface any geographic restrictions.

What is the difference between $159 and $179 pricing on the RightWell site?

As of this article's review of publicly available RightWell materials, the homepage headline displays $159 with a Spring Promo of $100 OFF auto-applied, while the brand's support center documentation references a starting price of $179. The most likely explanation is that $179 is the standard starting price and $159 reflects the promotional discount. Both prices are published by the brand; the promotional price may be time-limited. Confirm current pricing at the official RightWell site before completing enrollment, as promotional terms and pricing may change.

Is the RightWell video weight check for the guarantee private?

The Video Weight Check option - one of two ways to verify your weight for the 10% guarantee refund claim - involves recording a video showing your scale reading and submitting a unique verification code provided by RightWell's support team within 24 hours. The brand's Terms don't specify how long these videos are retained or the specific privacy handling. If this is a concern, the alternative is a signed letter from a licensed healthcare provider confirming your current weight. Direct specific privacy questions about the verification process to help@rightwell.com before submitting a claim.

What Buyers Who Describe Positive Experiences Say About RightWell

Based on publicly available consumer feedback on third-party platforms, buyers who describe positive experiences with RightWell's program tend to highlight the speed of the prescription process, the included ToneProtect™ supplement as a differentiator, the simplicity of the three-step enrollment, and the 24/7 patient portal access for clinical questions.

Common themes in feedback described as positive: the no-charge-until-prescribed model reduced enrollment anxiety; the refrigerated shipping was noted as professional and well-packaged; and the "doctor-approved" positioning resonated with buyers who wanted a clinical structure rather than a direct-to-consumer supplement.

Common themes in feedback described as mixed or critical: the pricing complexity (promotional vs. standard prices), the 4-week billing cycle vs. a perceived monthly billing expectation, and questions about medication appearance variation (the brand notes product appearance may vary with compounded preparations).

Customer ratings and testimonials are brand-reported, not independently audited by this publication. The brand's homepage explicitly notes: "Some testimonials on this site are of paid endorsers. Individual results may vary." Third-party reviews should be evaluated critically, with attention to verified-purchase indicators where available.

Buyer Takeaway: The most consistent positive signal from buyers who describe good experiences is the clinical structure and transparency - knowing that a licensed provider is actually reviewing their case rather than an automated approval system. The most consistent area of buyer confusion is the subscription billing frequency and pricing structure. Read the Terms of Use before you enroll.

How to Get Started With RightWell: Step-by-Step

Here's exactly what the enrollment process looks like, confirmed from published brand documentation:

• Step 1 - Take the quiz: Visit rightwell.com and complete the short online evaluation. This assesses whether GLP-1 therapy appears appropriate for your situation. Completing the quiz does not create a doctor-patient relationship.

• Step 2 - Complete the medical intake form: If the quiz indicates you may be a candidate, you'll complete a more detailed medical intake form covering your health history, current medications, and weight loss goals.

• Step 3 - Clinician review: A licensed U.S. clinician reviews your intake form. If appropriate, they schedule a telehealth consultation or directly approve your prescription. This step takes 24-48 hours after you've completed all intake requirements. Prescription is not guaranteed.

• Step 4 - Prescription issued and payment processed: Your card is charged only after the prescription is issued. You'll receive notification via the patient portal or email.

• Step 5 - Medication ships: Your order goes to a certified U.S. pharmacy partner. Medication ships refrigerated via 1-2 business-day priority shipping. Tracking information is provided within approximately 2 business days.

• Step 6 - Ongoing care via patient portal: Log in at app.rightwell.com for all clinical questions, dose discussions, and follow-up with your assigned care team. Administrative questions go to 1-800-634-2814 or help@rightwell.com.

Buyer Takeaway: The process is straightforward, and the no-charge-until-prescribed model means you can complete Steps 1-3 without financial commitment. The critical gate is Step 3 - the licensed clinician's independent review. That review is what makes this a clinical program rather than a supplement order.

Take the RightWell Assessment - No Charge Until Your Prescription Is Issued

15+ Verified Things to Know About RightWell Before You Enroll

• RightWell is a technology platform - it does not prescribe medication or employ clinicians. All prescribing decisions are made by the independent licensed medical practice.

• Your card is not charged until after your prescription is issued. Completing an intake form is not a financial commitment.

• Compounded GLP-1 medications are NOT FDA-approved, regardless of the platform. This is true of all compounded GLP-1 programs, including RightWell.

• Pharmacy partners operate in FDA-registered facilities, but their individual names are not publicly disclosed by RightWell.

• The 10% weight loss guarantee covers membership fees only - not medication costs, pharmacy fees, or shipping.

• Billing is every 4 weeks - approximately 13 billing events per year, not 12. This matters for budgeting.

• The $159 promotional price and $179 standard price are both published by the brand in different locations. Confirm current pricing before completing enrollment.

• ToneProtect™ is a dietary supplement with an FDA disclaimer - it has not been evaluated by the FDA and isn't intended to treat any disease.

• The insurance-backed dietitian referral is for dietitian services (potentially covered by your insurance) - not for the RightWell program costs themselves.

• Clinical support is exclusively through the patient portal for HIPAA compliance. Phone and email handle administrative issues only.

• If you've already been on GLP-1 therapy, you may be able to start at a higher dose by providing a prescription no older than 30 days.

• If your BMI is under 25, the standard program may not be available to you - but a Microdosing pathway exists and is worth asking about.

• The Spring Promo ($100 OFF, free ToneProtect™) was auto-applied as of June 2026 - but promotional pricing is subject to change and should be confirmed at checkout.

• Cancellation is by-period, not immediate. You're covered through the end of your current 4-week billing period after cancellation.

• Telehealth services are not for emergencies. Call 911 for any medical emergency. Don't wait for a patient portal response if you're experiencing acute symptoms.

• The FDA 503B enforcement docket (2026-08552, comment deadline June 29, 2026) is relevant to the long-term availability of compounded GLP-1 medications. Ask your clinician about this if you're making a multi-month commitment.

RightWell Buyer Takeaway - The Decision Framework

Here's the honest summary for someone who came to this article from a RightWell ad and wants to know whether to move forward:

RightWell's program structure includes several transparency signals that buyers should verify directly - the Terms of Use explicitly name the three entities involved, the guarantee terms are published in detail with specific eligibility criteria, the subscription billing cycle is disclosed, and the compounded (not FDA-approved) status of the medications is in the brand's own footer. That level of disclosure is a positive signal.

The clinical promise - that a licensed provider independently reviews your case before any prescription is issued and before any charge hits your card - is exactly how a responsible telehealth GLP-1 program should operate. You're not buying medication online; you're starting a clinical pathway where a licensed professional makes the prescribing decision.

The key things you need to verify before enrolling: the final pricing for your specific treatment tier (not just the headline $159/$179), the exact subscription terms and cancellation process, what your 10% guarantee would cover in your specific case (membership fees vs. total spend), and whether GLP-1 therapy is appropriate for you clinically - which only the licensed provider can determine.

If those boxes check out for your situation, RightWell's program offers a well-documented clinical pathway to compounded GLP-1 therapy with more published transparency than most of its category competitors.

See If You Qualify for RightWell's GLP-1 Program Today

Disclaimer and Disclosures

FDA and Product Status Disclosures. The following describes the regulatory status of the medications and supplements discussed in this article. These statements have not been evaluated by the Food and Drug Administration. Compounded medications referenced in this article are not intended to diagnose, treat, cure, or prevent any disease. GLP-1 medications discussed are compounded formulations and are not FDA-approved drug products. Dietary supplements discussed, including ToneProtect™, have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

FTC Material Connection Disclosure. This article contains affiliate links. A commission may be earned on qualifying purchases made through links in this content, at no additional cost to the reader. Affiliate relationships do not influence editorial content or the evaluation of products. Disclosure is provided in accordance with FTC 16 CFR Part 255. This content is promotional in nature and is intended for consumer education regarding a commercially available product.

Testimonial and Results Variability. Customer ratings and testimonials are brand-reported, not independently audited by this publication. The brand's homepage explicitly states: "Some testimonials on this site are of paid endorsers. Individual results may vary." All brand-reported statistics - including the 18% average weight loss, 92-93% retention rate, 6x comparative advantage, and 9/10 patient satisfaction - reflect self-reported user experiences and have not been independently substantiated by this publication. Individual results vary and depend on adherence to the treatment plan and provider guidance. No results are guaranteed.

Subscription and Auto-Renewal Disclosure (ROSCA/CA BPC §17600). RightWell's GLP-1 program operates as a continuous subscription that auto-renews every 4 weeks. Your payment method is charged automatically each period unless you cancel before the end of your current billing period. To cancel: visit rightwell.com/billing or email help@rightwell.com. Confirm current subscription terms, cancellation deadlines, and billing amounts at rightwell.com before completing enrollment. Price changes are communicated with at least 10 days' advance notice per brand Terms of Use.

Material Limitations of This Review. Here's what this article is based on and what it isn't. This review is based exclusively on publicly available materials, including the official RightWell website, the brand's published Terms of Use, Support Center documentation, and Privacy Practices. This publication has not received compensated product samples, has not interviewed RightWell personnel, has not been granted access to internal product specifications beyond what is publicly published, and has not conducted laboratory or field performance testing of compounded GLP-1 medications or ToneProtect™. Claims described as "according to the brand" or "brand-stated" reflect what the brand has publicly stated and have not been independently substantiated by this publication. Promotional language analyzed and discussed in the body of this article - including but not limited to brand-originated phrases such as "Doctor-Approved" and "Protects Muscle Tone" - originates with the RightWell brand's own published marketing materials and is identified in this article for consumer-education purposes, not as independent endorsement or performance guarantee. Buyers are encouraged to verify any claim that materially affects their purchase decision by contacting the brand directly at help@rightwell.com or 1-800-634-2814.

Third-Party Consumer Feedback Platforms. This article references the existence of third-party consumer feedback platforms in general category terms only. This publication does not endorse, vouch for, audit, or accept responsibility for the accuracy, completeness, or fairness of customer reviews posted on any third-party platform. Buyers consulting third-party reviews are encouraged to evaluate them critically, look for verified-purchase indicators where available, and weigh reviewer-specific context against their own situation.

Forward-Looking Statements and Article Accuracy. Prices, programs, and regulations change. Here's what this article was based on and what to verify before enrolling. This article reflects information available as of June 2026 and was prepared using reasonable care to be accurate and useful at the time of publication. Product specifications, pricing, promotional offers, subscription terms, guarantee terms, contact information, and clinical program details may change after publication without notice. The FDA 503B enforcement docket (2026-08552) referenced in this article has a public comment deadline of June 29, 2026; regulatory developments after publication date may affect the availability of compounded GLP-1 medications. No representation is made that the information will remain accurate in the future. Readers should rely on the official RightWell website (rightwell.com) as the authoritative source for current program information prior to any purchase decision.

Reasonable Consumer Standard. This is the standard any reasonable person should apply when reading a promotional article like this one. This article is written for a general adult consumer audience and intends statements to be interpreted as a reasonable consumer would interpret them in context. Where a statement could otherwise be read as a brand-substantiated fact, attribution language such as "according to the brand," "brand-stated," "brand-reported," or "per the brand's Terms" identifies it as a brand claim that has not been independently verified by this publication. Promotional language and marketing phrases appearing on the RightWell website - including, without limitation, "Doctor-Approved," "Protects Muscle Tone," "The Only GLP-1 Program," "6x more weight loss," "18% average body weight loss," "over 92% kept the weight off," and similar designations - are explicitly identified in this article (including in the "About the Promotional Language" section and the "How to Read RightWell's Marketing Language" section) as brand-asserted marketing language and are not represented as independent third-party rankings, performance guarantees, or laboratory-verified claims by this publication.

Geographic and Jurisdiction Disclosure. RightWell's program is available to adults located in U.S. states where the platform is active. Services are not available outside the United States. EU buyers should note that this article does not address EU consumer rights, EU data privacy rights under GDPR, or EU pricing display requirements under the Omnibus Directive. EU buyers should verify program availability, applicable consumer rights, and pricing compliance directly with the brand. The "before" pricing referenced in brand materials (e.g., promotional vs. standard prices) are the brand's stated reference points and may not reflect prevailing market prices; EU buyers should verify compliance with local reference pricing requirements.

California Proposition 65 Disclosure. California residents should review all medication labeling, supplement labeling, pharmacy documentation, and provider instructions for any applicable California-specific warnings, including Proposition 65 notices where provided by the pharmacy or manufacturer. Contact the brand at help@rightwell.com or your assigned licensed provider through the patient portal with any California-specific product questions.

Florida Weight-Loss Consumer Bill of Rights (§501.0575, Florida Statutes). WARNING: RAPID WEIGHT LOSS MAY CAUSE SERIOUS HEALTH PROBLEMS. RAPID WEIGHT LOSS IS WEIGHT LOSS OF MORE THAN 1½ POUNDS TO 2 POUNDS PER WEEK OR WEIGHT LOSS OF MORE THAN 1 PERCENT OF BODY WEIGHT PER WEEK AFTER THE SECOND WEEK OF PARTICIPATION IN A WEIGHT-LOSS PROGRAM. CONSULT YOUR PERSONAL PHYSICIAN BEFORE STARTING ANY WEIGHT-LOSS PROGRAM. ONLY PERMANENT LIFESTYLE CHANGES, SUCH AS MAKING HEALTHFUL FOOD CHOICES AND INCREASING PHYSICAL ACTIVITY, PROMOTE LONG-TERM WEIGHT LOSS. You have a right to ask questions about the potential health risks of this program and its nutritional content, psychological support, and educational components; receive an itemized statement of the actual or estimated price of the program; and know the estimated duration of the program.

Trademark Acknowledgment. ToneProtect™ is used with the ™ designation as shown on the official RightWell brand website. RightWell's registration status as a trademark was not confirmed on the brand's published materials as of the date of this article's preparation; use of the RightWell name in this article is nominative and for identification purposes only. Prescribey, Inc. is the registered legal entity name used as published in the brand's Terms of Use.

Telehealth Emergency Notice. Telehealth services facilitated by RightWell are not for medical emergencies or urgent situations. If you are experiencing a medical emergency, call 911 or your local emergency number immediately. Do not wait for a response through the patient portal.

Compounded Medication Disclosure. Compounded medications referenced in this article are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Compounded medications are prepared by licensed third-party U.S. pharmacy partners in FDA-registered facilities, per brand-stated materials. RightWell does not manufacture medications. Product appearance may vary.

No Affiliation With Featured Persons or Endorsers. This publication has no affiliation with any paid endorsers or individuals whose testimonials may appear on the RightWell official website. The brand's homepage explicitly discloses that "Some testimonials on this site are of paid endorsers." This publication has not independently verified the identity, compensation arrangement, or veracity of any testimonials published on the brand's website.

Contact Information for RightWell (Prescribey, Inc.): 1309 Coffeen Avenue Suite 1200, Sheridan, Wyoming 82801 | Phone: 1-800-634-2814 (Mon-Fri, 9am-6pm CST) | Email: help@rightwell.com | Patient Portal: app.rightwell.com/login

SOURCE: RightWell

Source: RightWell